• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白癜风中的调节性 T 细胞:对发病机制和治疗的影响。

Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.

出版信息

Autoimmun Rev. 2015 Jan;14(1):49-56. doi: 10.1016/j.autrev.2014.10.002.

DOI:10.1016/j.autrev.2014.10.002
PMID:25308528
Abstract

Vitiligo is a hypomelanotic autoimmune skin disease arising from a breakdown in immunological self-tolerance, which leads to aberrant immune responses against melanocytes. Regulatory T cells (Tregs) are crucial to the development of self-tolerance and so are major foci in the study of autoimmune pathogenesis of vitiligo. This review will summarise recent findings concerning the role of Tregs in the pathogenesis of vitiligo. In addition, as antigen-specific Tregs are a potential route for the reinstatement of immune tolerance, new strategies that expand or induce de novo generation of Tregs and which are currently being investigated as therapies for other autoimmune diseases, will be discussed. These approaches will highlight the opportunities for Treg cell-based therapeutics in vitiligo.

摘要

白癜风是一种由免疫自身耐受打破引起的色素减退性自身免疫性皮肤病,导致针对黑素细胞的异常免疫反应。调节性 T 细胞(Tregs)对自身耐受的发展至关重要,因此是白癜风自身免疫发病机制研究的重点。本综述将总结 Tregs 在白癜风发病机制中的作用的最新发现。此外,由于抗原特异性 Tregs 是恢复免疫耐受的潜在途径,因此将讨论目前正在作为其他自身免疫性疾病的治疗方法进行研究的扩展或诱导 Treg 新生的新策略。这些方法将突出 Treg 细胞治疗在白癜风中的应用机会。

相似文献

1
Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.白癜风中的调节性 T 细胞:对发病机制和治疗的影响。
Autoimmun Rev. 2015 Jan;14(1):49-56. doi: 10.1016/j.autrev.2014.10.002.
2
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.调节性 T 细胞在白癜风中的作用及治疗进展:迷你综述。
Inflamm Res. 2024 Aug;73(8):1311-1332. doi: 10.1007/s00011-024-01900-w. Epub 2024 Jun 5.
3
Treg cells in rheumatoid arthritis: an update.类风湿关节炎中的调节性 T 细胞:最新进展。
Curr Rheumatol Rep. 2013 Sep;15(9):352. doi: 10.1007/s11926-013-0352-0.
4
HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.HO-1 调节 Treg 功能:与白癜风免疫耐受的关联。
J Cell Mol Med. 2018 Sep;22(9):4335-4343. doi: 10.1111/jcmm.13723. Epub 2018 Jul 5.
5
Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.抗原特异性增强调节性 T 细胞在白癜风中的疾病控制作用。
Front Immunol. 2020 Dec 1;11:581433. doi: 10.3389/fimmu.2020.581433. eCollection 2020.
6
A quantitative increase in regulatory T cells controls development of vitiligo.调节性 T 细胞数量的增加可控制白癜风的发展。
J Invest Dermatol. 2014 May;134(5):1285-1294. doi: 10.1038/jid.2013.540. Epub 2013 Dec 23.
7
Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.活动性非节段型白癜风患者的调节性T细胞对CD8⁺CLA⁺T细胞的抑制能力较低。
Eur J Dermatol. 2014 Nov-Dec;24(6):676-82. doi: 10.1684/ejd.2014.2436.
8
Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.进展期白癜风患者外周调节性 T 淋巴细胞功能缺陷。
Pigment Cell Melanoma Res. 2012 Jan;25(1):99-109. doi: 10.1111/j.1755-148X.2011.00920.x. Epub 2011 Oct 25.
9
Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.肿瘤坏死因子家族 B 淋巴细胞激活因子在白癜风自身免疫中的可能作用。
Med Hypotheses. 2011 Mar;76(3):339-42. doi: 10.1016/j.mehy.2010.10.034. Epub 2010 Nov 13.
10
Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.全身性白癜风患者的 CD8+ 细胞毒性 T 淋巴细胞的整体激活与调节性 T 细胞的损伤有关。
PLoS One. 2012;7(5):e37513. doi: 10.1371/journal.pone.0037513. Epub 2012 May 23.

引用本文的文献

1
Cullin-3 and Regulatory Biomolecules Profiling in Vitiligo: Integrated Docking, Clinical, and In Silico Insights.白癜风中Cullin-3与调节性生物分子分析:综合对接、临床及计算机模拟见解
Biomolecules. 2025 Jul 21;15(7):1053. doi: 10.3390/biom15071053.
2
Emerging Therapeutic Innovations for Vitiligo Treatment.白癜风治疗的新兴治疗创新
Curr Issues Mol Biol. 2025 Mar 14;47(3):191. doi: 10.3390/cimb47030191.
3
Up-and-Coming Drugs for the Treatment of Vitiligo.治疗白癜风的新兴药物
Ann Dermatol. 2024 Aug;36(4):197-208. doi: 10.5021/ad.24.038.
4
Identifying the genetic association between common rheumatic diseases and vitiligo.鉴定常见风湿性疾病与白癜风之间的遗传关联。
Skin Res Technol. 2024 Jul;30(7):e13846. doi: 10.1111/srt.13846.
5
Aetiopathogenesis of Vitiligo.白癜风的病因发病机制
Dermatol Pract Concept. 2023 Dec 1;13(4S2):e2023314S. doi: 10.5826/dpc.1304S2a314S.
6
The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.氧化应激在白癜风中的作用:发病机制及治疗意义的最新研究进展。
Cells. 2023 Mar 19;12(6):936. doi: 10.3390/cells12060936.
7
Beyond skin white spots: Vitiligo and associated comorbidities.超越皮肤白斑:白癜风及其相关合并症。
Front Med (Lausanne). 2023 Feb 23;10:1072837. doi: 10.3389/fmed.2023.1072837. eCollection 2023.
8
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.白癜风:从发病机制到治疗进展的最新研究进展。
Int J Mol Sci. 2023 Mar 3;24(5):4910. doi: 10.3390/ijms24054910.
9
Regenerative Medicine-Based Treatment for Vitiligo: An Overview.基于再生医学的白癜风治疗:综述
Biomedicines. 2022 Oct 28;10(11):2744. doi: 10.3390/biomedicines10112744.
10
Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.Meta 分析:白癜风患者调节性 T 细胞频率和抑制能力的改变。
J Immunol Res. 2022 Sep 16;2022:6952299. doi: 10.1155/2022/6952299. eCollection 2022.